PALISADE BIO, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Palisade Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Palisade Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.59M, a 4.9% increase year-over-year.
  • Palisade Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$14.6M, a 6.3% decline year-over-year.
  • Palisade Bio, Inc. annual Operating Income (Loss) for 2023 was -$13.1M, a 16.9% increase from 2022.
  • Palisade Bio, Inc. annual Operating Income (Loss) for 2022 was -$15.7M, a 62.4% increase from 2021.
  • Palisade Bio, Inc. annual Operating Income (Loss) for 2021 was -$41.9M, a 350% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$14.6M -$3.59M +$185K +4.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$14.8M -$4.21M -$602K -16.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$14.2M -$3.67M -$1.14M -45.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$13.1M -$3.15M +$694K +18% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$13.8M -$3.78M +$635K +14.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$14.4M -$3.61M -$37K -1.04% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$14.4M -$2.53M +$1.36M +35% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$15.7M -$3.85M +$178K +4.42% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$15.9M -$4.41M -$1.4M -46.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$14.5M -$3.57M +$29.3M +89.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$43.8M -$3.89M -$1.93M -99% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$41.9M -$4.03M -$376K -10.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$41.5M -$3.02M -$1.2M -66.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$40.3M -$32.9M -$31M -1685% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$9.26M -$1.95M +$36.5K +1.83% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$9.3M -$3.65M -$1.52M -71.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$7.78M -$1.82M +$308K +14.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$8.09M -$1.84M +$77.4K +4.03% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$8.17M -$1.99M +$466K +19% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$8.63M -$2.13M -$328K -18.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$8.3M -$2.12M -$41.5K -1.99% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$8.26M -$1.92M +$105K +5.17% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$8.37M -$2.46M -$108K -4.58% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$8.26M -$1.8M +$464K +20.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$8.72M -$2.08M +$505K +19.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$9.23M -$2.02M +$2.2M +52% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$11.4M -$2.35M +$1.88M +44.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$13.3M -$2.27M +$3.38M +59.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$16.7M -$2.59M +$2.33M +47.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$19M -$4.22M -$384K -10% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$18.6M -$4.23M +$2M +32.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$20.6M -$5.65M -$1.3M -29.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$19.3M -$4.92M +$281K +5.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$19.6M -$3.83M +$1.16M +23.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$20.8M -$6.23M -$1.62M -35.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$19.2M -$4.35M +$290K +6.24% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-14
Q3 2015 -$19.4M -$5.2M -$1.09M -26.6% Jul 1, 2015 Sep 30, 2015 10-K 2016-03-14
Q2 2015 -$18.4M -$4.99M -$1.48M -42.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$16.9M -$4.61M +$564K +10.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$17.4M -$4.64M -$1.88M -68% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$15.6M -$4.11M -$473K -13% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$15.1M -$3.51M -$276K -8.52% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$14.8M -$5.18M -$2.29M -79% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$12.5M -$2.76M -$35.7K -1.31% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$12.5M -$3.63M -$1.05M -40.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$11.4M -$3.24M -$852K -35.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$10.6M -$2.89M -$429K -17.4% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$10.2M -$2.73M -$165K -6.43% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-10
Q3 2012 -$9.99M -$2.58M +$640K +19.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-10
Q2 2012 -$10.6M -$2.38M +$1.29M +35% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-10
Q1 2012 -$11.9M -$2.46M +$1.07M +30.3% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-10
Q4 2011 -$13M -$2.56M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-10
Q3 2011 -$3.22M +$701K +17.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$3.67M +$526K +12.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$3.54M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$3.92M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$4.2M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.